Antiproliferative effects of alkaloids from Sedum sarmentosum on murine and human hepatoma cell lines

被引:64
作者
Kang, TH
Pae, HO
Yoo, JC
Kim, NY
Kim, YC
Ko, GI
Chung, HT [1 ]
机构
[1] Wonkwang Univ, Coll Pharm, Iksan 570749, Chonbuk, South Korea
[2] Wonkwang Univ, Dept Microbiol & Immunol, Sch Med & Med Resources, Res Ctr, Iksan 570749, Chonbuk, South Korea
关键词
BNL CL.2; HepG2; Sedum sarmentosum; antiproliferation; anticancer; hepatitis;
D O I
10.1016/S0378-8741(99)00164-6
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The whole plant of Sedum sarmentosum (SS) has been traditionally used for the treatment of chronic viral hepatitis in China and South Korea. Certain hepatitis virus causes acute and chronic hepatitis and induces hepatocellular carcinoma (HC). In the present study, we examined whether the crude alkaloid fraction (CAF) of SS had any anticancer effects on hepatoma cell lines. Murine hepatoma (BNL CL.2) and human hepatoma (HepG2) cell lines were cultured in the presence of CAF of SS at various doses (50-150 mu g/ml) for 24 or 48 h. CAF caused a dose-dependent inhibition of cell proliferation without necrosis or apoptosis. Antiproliferative effects of CAF of SS were associated with an increase in the number of cells in the G1 phase of cell cycle. This study suggests that SS may improve survival of hepatoma patients via the inhibition of excessive growth of tumor cells. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 14 条
[1]  
Colombo M, 1998, RECENT RES CANCER, V154, P337
[2]   Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid [J].
Finstad, HS ;
Drevon, CA ;
Kulseth, MA ;
Synstad, AV ;
Knudsen, E ;
Kolset, SO .
BIOCHEMICAL JOURNAL, 1998, 336 :451-459
[3]   Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus-HCV vector [J].
Fipaldini, C ;
Bellei, B ;
La Monica, N .
VIROLOGY, 1999, 255 (02) :302-311
[4]   Hepatoprotective triterpenes from Sedum sarmentosum [J].
He, AM ;
Wang, MS ;
Hao, HY ;
Zhang, DC ;
Lee, KH .
PHYTOCHEMISTRY, 1998, 49 (08) :2607-2610
[5]   The increasing incidence of hepatocellular carcinoma [J].
Ince, N ;
Wands, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :798-799
[6]   Alkaloids of some Asian Sedum species [J].
Kim, JH ;
THart, H ;
Stevens, JF .
PHYTOCHEMISTRY, 1996, 41 (05) :1319-1324
[7]  
MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8
[8]   Factors predicting progression to cirrhosis and hepatocellular carcinoma in patients with transfusion-associated hepatitis C virus infection [J].
Murakami, C ;
Hino, K ;
Korenaga, M ;
Okazaki, M ;
Okuda, M ;
Nukui, K ;
Okita, K .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1999, 28 (02) :148-152
[9]   Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma [J].
Nakopoulou, L ;
Stefanaki, K ;
Vourlakou, C ;
Manolaki, N ;
Gakiopoulou, H ;
Michalopoulos, G .
PATHOLOGY RESEARCH AND PRACTICE, 1999, 195 (01) :19-24
[10]   Detection of hepatitis B surface antigen mutants and their integration in human hepatocellular carcinoma [J].
Oon, CJ ;
Chen, WN ;
Zhao, Y ;
Teng, SW ;
Leong, AL .
CANCER LETTERS, 1999, 136 (01) :95-99